Roche Holding

Annual Report
2015
P A T I E N T S
Positive late-stage clinical study
results on our investigational
medicine ocrelizumab in multiple
sclerosis give hope to people living
with this disease who need more
treatment options.
P
E
O
P
L
E
Keeping pace with our emerging
market growth, we are aiming
to increase the representation
of people with established and
developing region experience in
key leadership positions.
P A R T N E R S
New collaborations, such as the
strategic partnership...